Phase 3 Reflux Clinical Trials
6 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–6 of 6 trials
Recruiting
Phase 3
Domperidone in Treating Patients With Gastrointestinal Disorders
Nausea and VomitingGastroparesisDyspepsia+4 more
M.D. Anderson Cancer Center200 enrolled1 locationNCT01696734
Recruiting
Phase 3
Spinal Morphine or Intravenous Lidocaine in Robot-assisted Upper Urologic Surgery
Ureter CancerRenal CancerOther Specified Disorders of Kidney and Ureter+5 more
Hans Bahlmann220 enrolled3 locationsNCT06349668
Recruiting
Phase 3
A Clinical Trial of Anaprazole for Treating Reflux Esophagitis.
Reflux Esophagitis (RE)
Xuanzhu Biopharmaceutical Co., Ltd.500 enrolled1 locationNCT07010107
Recruiting
Phase 3
A Phase III Clinical Trial for Efficacy and Safety Evaluation of JP-1366 Tablets on Reflux Esophagitis
Reflux Esophagitis (RE)
Livzon Pharmaceutical Group Inc.356 enrolled1 locationNCT06850480
Not Yet Recruiting
Phase 3
The effect of intravenous sedation on the lower oesophageal sphincter: A comparison between dexmedetomidine and remifentanil in healthy adult volunteers.
Aspiration Risk during sedationReflux and sedation
Dr Islam Elhalawani16 enrolled1 locationACTRN12611000794909
Recruiting
Phase 3
A trial of position control therapy for treatment of infantile gastrooesophageal reflux.
infantile gastrooesophageal
reflux (GOR) disease
Children Women Youth Health Service200 enrolled1 locationACTRN12609000988257